Of the dozens of compounds tested by the NIA's Interventions Testing Program, 17α-estradiol is one of only a handful to extend male mouse lifespan reproducibly. It's not estrogen — it's a non-feminizing isomer with surprising metabolic effects. Here's what we know in 2026.
Most longevity-conscious consumers can name rapamycin and metformin as the leading geroprotector candidates. Far fewer have heard of 17-alpha-estradiol (17α-E2), despite the fact that it has produced reproducible male lifespan extension across multiple cohorts of the NIA's Interventions Testing Program (ITP) — the most rigorous longevity drug screening platform in existence. The compound is also one of the most biologically interesting in the longevity literature, because it has the metabolic benefits of estrogen without estrogenic feminizing effects.
This article explains what 17α-estradiol is, what the ITP and follow-up research show, why it's so different from regular estradiol, the human evidence to date, and how to think about it as a frontier longevity compound.
17β-estradiol is the dominant female reproductive estrogen, the one your body produces and the one used in conventional hormone replacement therapy. It binds the classical estrogen receptors (ERα and ERβ) with high affinity, producing the full estrogenic spectrum — feminization, breast tissue development, uterine effects, and so on.
17α-estradiol is the same molecule with the hydroxyl group at carbon 17 in the alpha rather than beta orientation — a stereoisomer. This single configuration change dramatically reduces binding to the classical estrogen receptors. 17α-E2 binds ERα and ERβ at roughly 1/100 to 1/200 the affinity of 17β-estradiol. As a result, it does not produce significant feminizing effects in males even at substantial doses.
But 17α-E2 retains affinity for several non-classical estrogen receptors and signaling pathways. It influences hepatic insulin sensitivity, hypothalamic feeding regulation, and inflammatory signaling — effects that mirror many of estrogen's metabolic benefits without the reproductive endocrine effects.